# FDA Inspection 803657 - BAYER PHARMA, AG - September 18, 2012

Source: https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/b86e49f0-3e12-47bb-bb4d-b311054042e7
Source feed: FDA_Inspections

> FDA Inspection 803657 for BAYER PHARMA, AG on September 18, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 803657
- Company Name: BAYER PHARMA, AG
- Inspection Date: 2012-09-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1282736 - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/1d238dca-b4e7-4c8f-8c8c-40de3cf1da86)
- [FDA Inspection 1239178 - 2021-08-27](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/45945a5c-5b62-45e5-93ff-085140511f3a)
- [FDA Inspection 1102816 - 2019-09-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/f4d6e717-a64d-42ca-931d-40fe4ad01598)
- [FDA Inspection 1001127 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/5e47f2e1-951b-482a-ad43-bb89fe81b130)
- [FDA Inspection 889209 - 2014-05-13](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/62dcd89d-3755-4ff0-bfd0-1cd68e1ec209)

Company: https://www.keypedia.com/companies/bayer-pharma-ag/28300a22-c506-4b1a-9052-6fc4e7170384

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c